CALLAN JMB INC.
Business
CALLAN JMB INC. is a vertically integrated logistics and fulfillment company providing thermal management logistics solutions for the life sciences industry. It offers proprietary specialty temperature-regulating reusable packaging, advanced monitoring technology (Sentry), inventory management software (Ship2Q®), emergency preparedness and response crews, and fulfillment services. Key business segments include specialty packaging, advanced monitoring/Sentry technology, fulfillment and emergency response services, and technical service offerings bundled with perishable logistics. The company serves primarily North American life sciences, government and institutional customers through direct contracts, leased packaging programs and rapid deployment logistics channels.
Summary from filing dated 2025-03-28
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Revenue | 6 | 7 | 13 | |
| Cost of revenue | 4 | 4 | 8 | |
| Gross profit | 2 | 3 | 6 | |
| Selling, general and administrative expenses | 9 | 5 | 3 | |
| Impairment loss on property and equipment | 542,088 | — | — | |
| Loss from operations | −7 | −2 | 2 | |
| Interest income | 8,691 | 11,904 | — | |
| Interest expense | −2,675 | −5,372 | −8,131 | |
| ELOC facility transaction expenses | −569,552 | — | — | |
| Changes in fair value of derivative liability (see Note 8) | −371,216 | — | — | |
| Total other income (expenses) | −934,752 | 6,532 | 2,045 | |
| Loss before income taxes | −8 | −2 | 2 | |
| Provision (benefit) for income taxes | −2,965 | 25,366 | 23,000 | |
| Net loss | −8 | −2 | 2 | |
| Weighted average common shares outstanding - basic | 4 | 3 | — | |
| Weighted average common shares outstanding - diluted | 4 | 3 | — | |
| Net loss per common share - basic | −1.82 | −0.87 | — | |
| Net loss per common share - diluted | −1.82 | −0.87 | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2025 2025-02-28 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 2 | — | 2 | 5 | — | |
| Accounts receivable, net of allowance for credit losses of $61,675 and $64,000, respectively | 343,246 | — | 622,914 | 3 | — | |
| Inventory | 243,285 | — | 158,362 | 114,739 | — | |
| Related party loans | — | — | 18,669 | 21,969 | — | |
| Tax refund receivable | — | — | 6,377 | — | — | |
| Other current assets | 341,311 | — | 278,896 | 235,987 | — | |
| Deferred offering costs | — | 188,832 | 136,025 | 25,000 | — | |
| Total current assets | 3 | — | 3 | 8 | — | |
| Right of use assets operating lease | 2 | — | 883,029 | 275,208 | — | |
| Property and equipment, net of accumulated depreciation of $760,655 and $608,703, respectively | 799,538 | — | 876,682 | 974,206 | — | |
| Security deposit | — | — | 3,650 | 3,650 | — | |
| Total assets | 6 | — | 5 | 10 | — | |
| Accounts payable | 564,014 | — | 371,661 | — | — | |
| Accrued expenses | 502,183 | — | 506,381 | — | — | |
| Corporate taxes payable | 23,085 | — | 23,000 | 67,000 | — | |
| Deferred revenue | — | — | 94,097 | 12,113 | — | |
| Right of use liability operating lease | 323,935 | — | 279,176 | 151,627 | — | |
| Total current liabilities | 1 | — | 1 | 769,706 | — | |
| Right of use liability operating lease | 2 | — | 628,274 | 132,488 | — | |
| Derivative liability | 371,216 | — | — | — | — | |
| Deferred tax liabilities | — | — | 6,602 | — | — | |
| Total long-term liabilities | 2 | — | 634,876 | 140,563 | — | |
| Total liabilities | 3 | — | 2 | 910,269 | — | |
| Commitments and contingencies Note 7 | — | — | — | — | — | |
| Preferred stock - authorized 10,000,000 shares, $0.001 par value; zero issued and outstanding as of December 31, 2025 and December 31, 2024 | — | — | — | — | — | |
| Common stock - authorized 190,000,000 shares, par value $0.001 par value; 4,858,663 issued and outstanding as of December 31, 2025 and 3,000,000 December 31, 2024 | 4,860 | — | 3,000 | — | — | |
| Additional paid in capital | 13 | — | 5 | — | — | |
| Accumulated deficit | −10 | — | −2 | — | — | |
| Total stockholders equity | 2 | — | 3 | 9 | 14 | |
| Total liabilities and stockholders equity | 6 | — | 5 | 10 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Provision (Recovery) for credit losses | 230,190 | −131,000 | 277,000 | |
| Depreciation and amortization | 151,952 | 143,691 | — | |
| Other non-cash expenses relating to ELOC Facility | 519,552 | — | — | |
| Stock based compensation | 2 | — | — | |
| Impairment loss on property and equipment | 542,088 | — | — | |
| Accounts receivable | 49,478 | 2 | 5 | |
| Inventory | −84,923 | −43,623 | −35,294 | |
| Tax refund receivable | 6,377 | −6,377 | — | |
| Other current assets | −58,765 | −42,909 | 115,630 | |
| Operating lease liabilities | 45,180 | 15,514 | −817 | |
| Accounts payable and accrued expenses | 188,155 | 461,958 | −251,542 | |
| Deferred revenue | −94,097 | 73,909 | 20,188 | |
| Corporate taxes payable | 85 | −44,000 | −43,000 | |
| Deferred tax liabilities | −6,602 | −398 | — | |
| Net cash provided by (used in) operating activities | −5 | 540,353 | 7 | |
| Purchase of property and equipment | −616,896 | −46,167 | −490,020 | |
| Net cash used in investing activity | −616,896 | −46,167 | −490,020 | |
| Related party receivable | — | 3,300 | — | |
| Related party loans | 18,669 | −17,073 | −5,337 | |
| Deferred offering costs | 136,025 | −111,025 | — | |
| Partner distributions | — | −3 | −7 | |
| Net change note payable | — | −98,809 | −133,565 | |
| Proceeds from IPO and overallotment, net | 5 | — | — | |
| Proceeds from offering of ELOC shares | 497,750 | — | — | |
| Net cash provided by (used in) financing activities | 5 | −4 | −8 | |
| Increase (decrease) in cash and cash equivalents | 32,813 | −3 | −1 | |
| Cash paid for interest | 2,675 | 5,372 | 8,131 | |
| Initial recognition of derivative liability | 974,309 | — | — | |
| Right of use assets acquired and corresponding operating lease liability | 708,321 | — | — | |
| Right-of-use assets and corresponding lease liabilities due to lease modifications | 628,407 | 900,133 | — | |
| Reduction in allowance for credit losses | — | 163,000 | — | |
| Membership exchange for common stock | — | 5 | — | |
| Fair value of Stock Warrants issued at IPO | 144,358 | — | — | |
| Deferred offering costs charged to additional paid-in-capital | 136,025 | — | — | |
| Par value of shares issued for restricted stock award units vesting | 75 | — | — | |
| Commitment shares adjustment to APIC | 78,000 | — | — | |
| Other non-cash ELOC expenses | 441,552 | — | — |